![Neil McFarlane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil McFarlane
Algemeen Directeur bij
ZEVRA THERAPEUTICS, INC.
Vermogen: 4 M $ op 31-05-2026
Profiel
Neil F.
McFarlane is President, Chief Executive Officer & Director at Zevra Therapeutics, Inc. since 2023.
Former roles include Chief Executive Officer at Adamas Pharmaceuticals LLC from 2019 to 2021, Independent Director at Collegium Pharmaceutical, Inc. from 2022 to 2024, Vice President & General Manager at UCB, Inc. from 2011 to 2016, and Chief Operating Officer at Travere Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate and graduate degrees from the University of Florida.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-04-2026 | 304.282 ( 0,51% ) | 4 M $ | 31-05-2026 |
Actieve functies van Neil McFarlane
| Bedrijven | Functie | Begin |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Algemeen Directeur | 10-10-2023 |
Eerdere bekende functies van Neil McFarlane
| Bedrijven | Functie | Einde |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Directeur/Bestuurslid | 28-07-2024 |
| ADAMAS PHARMACEUTICALS, INC. | Algemeen Directeur | 01-11-2021 |
| TRAVERE THERAPEUTICS, INC. | Operationeel Directeur | 31-05-2019 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Neil McFarlane
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
20
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
